SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-024498
Filing Date
2024-03-21
Accepted
2024-03-21 07:05:08
Documents
3
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0202042-6k_inflarxnv.htm 6-K 10320
2 PRESS RELEASE, DATED MARCH 21, 2024 ea020204201ex99-1_inflarxnv.htm EX-99.1 163517
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2954
  Complete submission text file 0001213900-24-024498.txt   179135
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 24769381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)